Merck Biopharma Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 10,001

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 11

Merck Biopharma General Information

Description

Operator of bio pharmaceutical company. The company specializes in the manufacturing of cancer and cardiovascular drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany
+49 06151
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Frankfurter Straße 250
  • 64293 Darmstadt
  • Germany
+49 06151

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merck Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merck Biopharma‘s full profile, request access.

Request a free trial

Merck Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of bio pharmaceutical company. The company specializes in the manufacturing of cancer and cardiovascular drugs.
Other Pharmaceuticals and Biotechnology
Darmstadt, Germany
10,001 As of 2014

Basel, Switzerland
 

Ravensburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merck Biopharma Competitors (17)

One of Merck Biopharma’s 17 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lonza Group Corporation Basel, Switzerland
Vetter Pharma Private Debt Financed Ravensburg, Germany
Eisai Corporation Tokyo, Japan
Sandoz Corporation Basel, Switzerland
BSP Pharmaceuticals Corporation Latina Scalo, Italy
You’re viewing 5 of 17 competitors. Get the full list »

Merck Biopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merck Biopharma Investments & Acquisitions (11)

Merck Biopharma’s most recent deal was a Grant with VAR2 Pharma for . The deal was made on 06-Jul-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
VAR2 Pharma 06-Jul-2020 Grant Drug Discovery
HQS Quantum Simulations 01-Jan-2018 Grant Business/Productivity Software
GQ Bio Therapeutics 15-Dec-2016 Grant Drug Discovery
Fresh Strips 22-Sep-2016 Grant Other Containers and Packaging
Shift.ms 01-Jan-2015 Grant Social Content
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Merck Biopharma Exits (6)

Merck Biopharma’s most recent exit was on 15-Dec-2016 from GQ Bio Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
GQ Bio Therapeutics 15-Dec-2016 Completed
Fresh Strips 22-Sep-2016 Completed
Neviah Genomics 25-Jun-2012 Completed
  • 3 buyers
Merck Serono & BioMarin Pharmaceutical (Kuvan Rights) 01-Jan-2005 Completed
Merck Serono & BioMarin Pharmaceutical (Kuvan Rights) Corporate Asset Purchase Completed
You’re viewing 5 of 6 exits. Get the full list »

Merck Biopharma FAQs

  • Where is Merck Biopharma headquartered?

    Merck Biopharma is headquartered in Darmstadt, Germany.

  • What is the size of Merck Biopharma?

    Merck Biopharma has 10,001 total employees.

  • What industry is Merck Biopharma in?

    Merck Biopharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Merck Biopharma a private or public company?

    Merck Biopharma is a Private company.

  • What is Merck Biopharma’s current revenue?

    The current revenue for Merck Biopharma is .

  • How much funding has Merck Biopharma raised over time?

    Merck Biopharma has raised $14.8B.

  • Who are Merck Biopharma’s competitors?

    Lonza Group, Vetter Pharma, Eisai, Sandoz, and BSP Pharmaceuticals are some of the 17 competitors of Merck Biopharma.

  • When was Merck Biopharma acquired?

    Merck Biopharma was acquired on 07-Feb-2007.

  • Who acquired Merck Biopharma?

    Merck Biopharma was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process